The Saudi Food and Drug Authority (SFDA) is organizing a Generic Drug Conference, titled "Empowering Local Pharmaceutical Manufacturing: The Future of Generic Drugs in Saudi Arabia," on Tuesday, December 30, 2025, in Riyadh. The conference aims to build a resilient, sustainable pharmaceutical sector that supports public health.

The conference will serve as a unique platform bringing together healthcare providers, regulatory experts, academics, investors, and major pharmaceutical companies to foster open dialogue, share global best practices, and align efforts towards strengthening the generic drug sector within Saudi Arabia.

The conference agenda is carefully designed to address critical strategic themes, including: the national efforts for enhancing drug security; investment and regulatory enablers for generic drug manufacturing; pharmaceutical R&D and formulation challenges; pricing, reimbursement, and market access policies; and supply chain resilience and Good Manufacturing Practice (GMP) compliance, all aimed at strengthening public confidence in generics.

The SFDA Generic Drug Conference comes at a pivotal time in Saudi Arabia's healthcare and pharmaceutical sectors. With the ambitious Saudi Vision 2030 driving economic diversification and healthcare transformation, the local pharmaceutical industry stands as a cornerstone for national drug security, public health sustainability, and economic growth.

For registration and further details, please visit the official website: https://sfda-gdc.com/